| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/23/2002 | US6423683 Microdose therapy |
| 07/23/2002 | US6423539 Enhancing immunology response |
| 07/23/2002 | US6423527 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/23/2002 | US6423516 Process and agent for instabilizing viral quasi-species-distributions avoiding resistance phenomena |
| 07/23/2002 | US6423507 Detecting enzyme inhibitors; obtain protease, incubate with modulator, monitor adjustment in protease activity |
| 07/23/2002 | US6423349 Compositions comprising glutamine in combination with other nutrients, including n-acetyl-cysteine and vitamins a, c, e are disclosed. |
| 07/23/2002 | US6423344 Dispersion of dry powders, atomizing, drying and accumulation of particles |
| 07/23/2002 | US6423343 Antiinflammatory agents for skins |
| 07/23/2002 | US6423342 Fast dispersing composition with selegiline |
| 07/23/2002 | US6423341 A beta -lactam antibiotic-containing tablet which comprises a beta-lactam antibiotic such as cefixime or cefdinir, a low-substituted hydroxypropylcellulose and/or crosslinked polyvinylpyrrolidone as disintegrator and a binder |
| 07/23/2002 | US6423340 Gastrointestinal disorders, crohn's colitis |
| 07/23/2002 | US6423338 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 07/23/2002 | US6423327 Treating wrinkles of skin with adenosine |
| 07/23/2002 | US6423320 Inhibitor of immunoglobulin E antibody production |
| 07/23/2002 | US6423311 Mammals grafting cells with radiation |
| 07/23/2002 | US6423307 For use in the topical treatment of mucosal affections |
| 07/23/2002 | US6423300 Compositions to control oral microbial oxidation-reduction (Eh) levels |
| 07/23/2002 | US6423298 Pharmaceutical formulations for aerosols with two or more active substances |
| 07/23/2002 | US6423256 Process for producing solid dosage forms |
| 07/23/2002 | US6423039 Synchronizing of animal oestrus and intra vaginal devices useful therein |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2107675C Antibiotic carbapenem derivatives |
| 07/23/2002 | CA2102180C Novel immunosuppressive pyrrolidine/piperidine/azepane-2-carboxylic acid derivatives |
| 07/23/2002 | CA2097827C Enhanced bioavailability pharmaceutical composition containing probucol |
| 07/23/2002 | CA2087723C Treatment with flurbiprofen of pain and inflammation in mammals |
| 07/23/2002 | CA2058597C Wound healing compositions containing fibroblast growth factor and ascorbic acid |
| 07/23/2002 | CA2055257C Saccharide for supplementing energy to living body, and uses |
| 07/23/2002 | CA2042503C Novel bifunctional linking compounds, conjugates and methods for their production |
| 07/23/2002 | CA2041594C Pyrido[2,3-f][1,4]thiazepines and pyrido[3,2-b][1,5]benzothiazepines |
| 07/23/2002 | CA2040865C Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor |
| 07/22/2002 | CA2368485A1 Combination treatment for depression |
| 07/18/2002 | WO2002056027A2 Regulation of neutral development by daedalos |
| 07/18/2002 | WO2002056022A2 Diagnostics, drug screening and treatment for cancer |
| 07/18/2002 | WO2002055720A2 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 07/18/2002 | WO2002055700A2 Human genes and gene expression products isolated from human prostate |
| 07/18/2002 | WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | WO2002055694A2 Discriminative nucleic acid analysis using clone sequence signatures |
| 07/18/2002 | WO2002055693A2 Method for inhibiting the expression of a target gene |
| 07/18/2002 | WO2002055692A2 Method for inhibiting the expression of a target gene and medicament for treating a tumor disease |
| 07/18/2002 | WO2002055691A1 Gene encoding aip-1/flash promoter and use thereof |
| 07/18/2002 | WO2002055688A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms |
| 07/18/2002 | WO2002055661A2 Fatty acid synthase inhibitors |
| 07/18/2002 | WO2002055639A1 A process for the preparation of a fat composition containing sterol esters a product obtained by said process and the use thereof |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055541A2 Peptides having inhibiting activity on the production of nitric oxide |
| 07/18/2002 | WO2002055533A2 Methods of using imxp-888 and imxp-888 antagonists |
| 07/18/2002 | WO2002055531A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 07/18/2002 | WO2002055524A1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 07/18/2002 | WO2002055523A1 Mikanolide derivatives, their preparation and therapeutic uses |
| 07/18/2002 | WO2002055522A2 Novel multi-ring organic compounds for regulating gut motility and food intake |
| 07/18/2002 | WO2002055521A1 Purine derivatives as purinergic receptor antagonists |
| 07/18/2002 | WO2002055519A2 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 07/18/2002 | WO2002055518A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists |
| 07/18/2002 | WO2002055517A2 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | WO2002055515A1 Chemical derivatives and their use as anti-telomerase agent |
| 07/18/2002 | WO2002055514A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 07/18/2002 | WO2002055510A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 07/18/2002 | WO2002055507A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors |
| 07/18/2002 | WO2002055506A1 Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop, and nasal drop |
| 07/18/2002 | WO2002055502A1 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 07/18/2002 | WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | WO2002055498A1 Pharmaceutically active piperidine derivatives |
| 07/18/2002 | WO2002055497A1 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055496A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055495A1 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055492A2 An improved process for preparing pure ondansetron hydrochloride dihydrate |
| 07/18/2002 | WO2002055490A2 Metabolic controlled fermentation process for carbamoyl tobramycin production |
| 07/18/2002 | WO2002055489A2 Pim kinase-related methods |
| 07/18/2002 | WO2002055485A1 Prodrugs of excitatory amino acids |
| 07/18/2002 | WO2002055481A1 Prodrugs of excitatory amino acids |
| 07/18/2002 | WO2002055136A2 Intrasvascular drug delivery device and use therefor |
| 07/18/2002 | WO2002055121A1 Drug delivery from stents |
| 07/18/2002 | WO2002055108A1 Targeted modification of intracellular compounds |
| 07/18/2002 | WO2002055107A1 Topical anesthesia compositions |
| 07/18/2002 | WO2002055106A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 07/18/2002 | WO2002055095A2 Use of aziridino-compounds in the treatment of immune dysfunctions |
| 07/18/2002 | WO2002055093A2 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages |
| 07/18/2002 | WO2002055092A1 Preventives and/or remedies for digestive diseases |
| 07/18/2002 | WO2002055090A1 Preventives for microbial infections |
| 07/18/2002 | WO2002055089A2 Immunoassay technique using multispecific molecules |
| 07/18/2002 | WO2002055088A1 Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents |
| 07/18/2002 | WO2002055087A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 07/18/2002 | WO2002055086A2 Hormone replacement therapy method and its administration form |
| 07/18/2002 | WO2002055085A2 Use of an adenosine a3 receptor agonist for inhibition of viral replication |
| 07/18/2002 | WO2002055084A1 PYRROLO[2,3-d]PYRIMIDINE AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 07/18/2002 | WO2002055083A1 TRIAZOLO[4,5-d] PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 07/18/2002 | WO2002055082A1 Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists |
| 07/18/2002 | WO2002055081A2 Use of chelators in the treatment of macular degenerative disease |
| 07/18/2002 | WO2002055080A2 Method of immunomodulation using thione-forming disulfides |
| 07/18/2002 | WO2002055079A2 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 07/18/2002 | WO2002055078A2 Use of chromanes for treating parkinson's disease |
| 07/18/2002 | WO2002055077A1 Use of imidazolyl cyclic acetal derivatives in the manufacture of a medicament for the treatment of diseases mediated by the alk5 receptors |
| 07/18/2002 | WO2002055076A1 Cyclodextrin-containing pharmaceutical preparation |
| 07/18/2002 | WO2002055075A2 Compounds and methods for regulating cell differentiation |
| 07/18/2002 | WO2002055074A1 Preventives or remedies for arthritis |
| 07/18/2002 | WO2002055073A1 Preventives for arthritis |
| 07/18/2002 | WO2002055072A1 Regulation of lipids and/or bone density and compositions therefor |
| 07/18/2002 | WO2002055071A1 Compositions and methods for regulating lipoproteins and hypercholesterolmia with limonoids flavonoids and tocotrienols |
| 07/18/2002 | WO2002055070A1 Dihydrofuran cyclic tanshintones used in treating hyperammonemia and hepatic encephalopathy |
| 07/18/2002 | WO2002055069A1 Use of betaine in functional products having blood pressure lowering effects |